Assembly Biosciences, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 398.01%332.94%29,179.87%-575.00%-605.59%-616.48%-986.54%-2,116.82%-854.32%-139.72%
EBIT Margin 298.02%233.22%29,145.30%-579.08%-626.42%-643.44%-1,028.19%-2,121.65%-902.50%-159.26%
EBITDA Margin 298.02%233.22%29,145.30%-472.34%-612.71%-610.71%-987.63%-2,078.73%-844.70%-141.33%
Operating Margin 298.02%233.22%29,145.30%-579.08%-626.42%-643.44%-1,028.19%-2,121.65%-902.50%-159.26%
Net Margin 398.01%332.94%29,179.87%-474.65%-613.02%-611.63%-986.54%-2,076.35%-854.78%-140.87%
FCF Margin 311.07%255.15%21,498.32%11.03%-441.08%-536.37%-1,006.78%-1,542.88%313.95%-179.33%
Efficiency
Assets Average 115.93M133.71M218.67M303.98M311.58M237.16M146.43M119.31M128.00M
Equity Average 99.31M96.50M161.89M241.94M256.90M204.75M125.80M61.88M37.23M
Invested Capital 118.74M79.88M113.12M210.65M273.22M240.58M168.93M82.66M41.10M33.36M
Asset Utilization Ratio 0.070.070.050.020.030.060.22
Leverage & Solvency
Interest Coverage Ratio -2.98-2.33-291.45
Equity Ratio 0.890.810.670.790.800.850.880.810.300.28
Times Interest Earned -2.98-2.33-291.45
Valuation
Enterprise Value 90.09M99.35M83.69M61.70M156.33M667.30M357.90M258.88M-16.63M-35.11M-28.20M-76.36M-11.78M
Market Capitalization 90.09M99.35M83.69M129.36M209.29M787.25M575.98M532.92M199.79M111.52M63.41M53.89M100.30M
Return Ratios
Return on Sales 3.98%3.33%291.80%-4.75%-6.13%-6.12%-9.87%-20.76%-8.55%-1.41%
Return on Capital Employed -0.42%-0.43%-0.46%-0.37%-0.23%-0.60%-0.72%-0.81%-0.57%
Return on Invested Capital -0.45%-0.45%-0.42%-0.64%
Return on Assets -0.38%-0.32%-0.42%-0.32%-0.20%-0.55%-0.64%-0.51%-0.31%
Return on Equity -0.45%-0.44%-0.56%-0.40%-0.24%-0.63%-0.74%-0.99%-1.08%